STOX1 and preeclampsia: To achieve this, the induction ratio of the 265 genes found to be transcriptionnally modified in the preeclampsia study of Nishizawa and co-workers [8], were plotted against the ratio of induction/down-regulation of the same genes in the JEG-3 cells overexpressing STOX1. Strikingly, the correlation applied between genes whose expression is affected by STOX1 and preeclampsia-modified genes was highly significant (r = 0.295, p = 9.8 10−7, Figure 4).